About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Urinary Tract Infection Therapeutics Market Size, Trends & Growth Analysis | 2031

Urinary Tract Infection Therapeutics Market

Urinary Tract Infection Therapeutics Market Size, Share & Trends Analysis Report By Drug (Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, Other Drugs), By Indication (Complicated UTI, Uncomplicated UTI, Other Indications) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI3425DR
Study Period 2019-2031 CAGR 3.2%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 8.92 Billion
Forecast Year 2031 Forecast Year Market Size USD 11.85 Billion
Largest Market North America Fastest Growing Market Europe
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Urinary Tract Infection Therapeutics Market, By Drug (2021-2031)
    1. Penicillin and Combinations
    2. Quinolones
    3. Cephalosporin
    4. Azoles and Amphotericin B
    5. Nitrofurans
    6. Other Drugs
  2. Urinary Tract Infection Therapeutics Market, By Indication (2021-2031)
    1. Complicated UTI
    2. Uncomplicated UTI
    3. Other Indications
    1. North America
      1. North America Urinary Tract Infection Therapeutics Market, By Drug
        1. Penicillin and Combinations
          1. Quinolones
            1. Cephalosporin
              1. Azoles and Amphotericin B
                1. Nitrofurans
                  1. Other Drugs
                  2. North America Urinary Tract Infection Therapeutics Market, By Indication
                    1. Complicated UTI
                      1. Uncomplicated UTI
                        1. Other Indications
                        2. U.S.
                          1. U.S. Urinary Tract Infection Therapeutics Market, By Drug
                            1. Penicillin and Combinations
                              1. Quinolones
                                1. Cephalosporin
                                  1. Azoles and Amphotericin B
                                    1. Nitrofurans
                                      1. Other Drugs
                                      2. U.S. Urinary Tract Infection Therapeutics Market, By Indication
                                        1. Complicated UTI
                                          1. Uncomplicated UTI
                                            1. Other Indications
                                          2. Canada
                                        2. Europe
                                          1. Europe Urinary Tract Infection Therapeutics Market, By Drug
                                            1. Penicillin and Combinations
                                              1. Quinolones
                                                1. Cephalosporin
                                                  1. Azoles and Amphotericin B
                                                    1. Nitrofurans
                                                      1. Other Drugs
                                                      2. Europe Urinary Tract Infection Therapeutics Market, By Indication
                                                        1. Complicated UTI
                                                          1. Uncomplicated UTI
                                                            1. Other Indications
                                                            2. U.K.
                                                              1. U.K. Urinary Tract Infection Therapeutics Market, By Drug
                                                                1. Penicillin and Combinations
                                                                  1. Quinolones
                                                                    1. Cephalosporin
                                                                      1. Azoles and Amphotericin B
                                                                        1. Nitrofurans
                                                                          1. Other Drugs
                                                                          2. U.K. Urinary Tract Infection Therapeutics Market, By Indication
                                                                            1. Complicated UTI
                                                                              1. Uncomplicated UTI
                                                                                1. Other Indications
                                                                              2. Germany
                                                                              3. France
                                                                              4. Spain
                                                                              5. Italy
                                                                              6. Russia
                                                                              7. Nordic
                                                                              8. Benelux
                                                                              9. Rest of Europe
                                                                            2. APAC
                                                                              1. APAC Urinary Tract Infection Therapeutics Market, By Drug
                                                                                1. Penicillin and Combinations
                                                                                  1. Quinolones
                                                                                    1. Cephalosporin
                                                                                      1. Azoles and Amphotericin B
                                                                                        1. Nitrofurans
                                                                                          1. Other Drugs
                                                                                          2. APAC Urinary Tract Infection Therapeutics Market, By Indication
                                                                                            1. Complicated UTI
                                                                                              1. Uncomplicated UTI
                                                                                                1. Other Indications
                                                                                                2. China
                                                                                                  1. China Urinary Tract Infection Therapeutics Market, By Drug
                                                                                                    1. Penicillin and Combinations
                                                                                                      1. Quinolones
                                                                                                        1. Cephalosporin
                                                                                                          1. Azoles and Amphotericin B
                                                                                                            1. Nitrofurans
                                                                                                              1. Other Drugs
                                                                                                              2. China Urinary Tract Infection Therapeutics Market, By Indication
                                                                                                                1. Complicated UTI
                                                                                                                  1. Uncomplicated UTI
                                                                                                                    1. Other Indications
                                                                                                                  2. Korea
                                                                                                                  3. Japan
                                                                                                                  4. India
                                                                                                                  5. Australia
                                                                                                                  6. Taiwan
                                                                                                                  7. South East Asia
                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                2. Middle East and Africa
                                                                                                                  1. Middle East and Africa Urinary Tract Infection Therapeutics Market, By Drug
                                                                                                                    1. Penicillin and Combinations
                                                                                                                      1. Quinolones
                                                                                                                        1. Cephalosporin
                                                                                                                          1. Azoles and Amphotericin B
                                                                                                                            1. Nitrofurans
                                                                                                                              1. Other Drugs
                                                                                                                              2. Middle East and Africa Urinary Tract Infection Therapeutics Market, By Indication
                                                                                                                                1. Complicated UTI
                                                                                                                                  1. Uncomplicated UTI
                                                                                                                                    1. Other Indications
                                                                                                                                    2. UAE
                                                                                                                                      1. UAE Urinary Tract Infection Therapeutics Market, By Drug
                                                                                                                                        1. Penicillin and Combinations
                                                                                                                                          1. Quinolones
                                                                                                                                            1. Cephalosporin
                                                                                                                                              1. Azoles and Amphotericin B
                                                                                                                                                1. Nitrofurans
                                                                                                                                                  1. Other Drugs
                                                                                                                                                  2. UAE Urinary Tract Infection Therapeutics Market, By Indication
                                                                                                                                                    1. Complicated UTI
                                                                                                                                                      1. Uncomplicated UTI
                                                                                                                                                        1. Other Indications
                                                                                                                                                      2. Turkey
                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                      4. South Africa
                                                                                                                                                      5. Egypt
                                                                                                                                                      6. Nigeria
                                                                                                                                                      7. Rest of MEA
                                                                                                                                                    2. LATAM
                                                                                                                                                      1. LATAM Urinary Tract Infection Therapeutics Market, By Drug
                                                                                                                                                        1. Penicillin and Combinations
                                                                                                                                                          1. Quinolones
                                                                                                                                                            1. Cephalosporin
                                                                                                                                                              1. Azoles and Amphotericin B
                                                                                                                                                                1. Nitrofurans
                                                                                                                                                                  1. Other Drugs
                                                                                                                                                                  2. LATAM Urinary Tract Infection Therapeutics Market, By Indication
                                                                                                                                                                    1. Complicated UTI
                                                                                                                                                                      1. Uncomplicated UTI
                                                                                                                                                                        1. Other Indications
                                                                                                                                                                        2. Brazil
                                                                                                                                                                          1. Brazil Urinary Tract Infection Therapeutics Market, By Drug
                                                                                                                                                                            1. Penicillin and Combinations
                                                                                                                                                                              1. Quinolones
                                                                                                                                                                                1. Cephalosporin
                                                                                                                                                                                  1. Azoles and Amphotericin B
                                                                                                                                                                                    1. Nitrofurans
                                                                                                                                                                                      1. Other Drugs
                                                                                                                                                                                      2. Brazil Urinary Tract Infection Therapeutics Market, By Indication
                                                                                                                                                                                        1. Complicated UTI
                                                                                                                                                                                          1. Uncomplicated UTI
                                                                                                                                                                                            1. Other Indications
                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                          4. Chile
                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                      Related Reports

                                                                                                                                                                                      Global Report
                                                                                                                                                                                      The global urinary tract infection market size was valued at USD 9.25 Billion in 2023. It is projected to reach USD 12.18 Billion by 2032, growing at a CAGR of 3.2% during the forecast period (2024-2032). Factors such as combinational drug launch, pr
                                                                                                                                                                                      Buy Now

                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                      • Permission to print the report

                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                      www.straitsresearch.com
                                                                                                                                                                                      © Copyright . All rights Reserved.